ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 118 filers reported holding ANAPTYSBIO INC in Q4 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,158 | -8.4% | 56,926 | -2.0% | 0.01% | -40.0% |
Q1 2023 | $1,264 | +19.1% | 58,090 | +69.7% | 0.02% | +15.4% |
Q4 2022 | $1,061 | -99.8% | 34,235 | +62.9% | 0.01% | +85.7% |
Q3 2022 | $536,000 | +4.1% | 21,021 | -17.2% | 0.01% | +40.0% |
Q2 2022 | $515,000 | -85.4% | 25,374 | -80.5% | 0.01% | -70.6% |
Q3 2021 | $3,524,000 | +15.3% | 129,936 | +10.3% | 0.02% | +21.4% |
Q2 2021 | $3,056,000 | +23.0% | 117,848 | +2.2% | 0.01% | +7.7% |
Q1 2021 | $2,484,000 | +12.4% | 115,262 | +12.1% | 0.01% | +8.3% |
Q4 2020 | $2,210,000 | +49.8% | 102,811 | +2.8% | 0.01% | +33.3% |
Q3 2020 | $1,475,000 | +1080.0% | 100,020 | +1691.2% | 0.01% | +800.0% |
Q2 2020 | $125,000 | -17.8% | 5,584 | -40.4% | 0.00% | 0.0% |
Q4 2019 | $152,000 | -77.9% | 9,375 | -52.2% | 0.00% | -83.3% |
Q3 2019 | $687,000 | +467.8% | 19,632 | +1080.5% | 0.01% | +500.0% |
Q1 2019 | $121,000 | -4.0% | 1,663 | -15.8% | 0.00% | 0.0% |
Q4 2018 | $126,000 | -27.2% | 1,975 | +18.8% | 0.00% | 0.0% |
Q1 2018 | $173,000 | – | 1,662 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |